Nila U. Parikh

3.1k total citations
39 papers, 2.5k citations indexed

About

Nila U. Parikh is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Nila U. Parikh has authored 39 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Nila U. Parikh's work include PI3K/AKT/mTOR signaling in cancer (10 papers), Liver physiology and pathology (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Nila U. Parikh is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (10 papers), Liver physiology and pathology (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Nila U. Parikh collaborates with scholars based in United States, Spain and United Kingdom. Nila U. Parikh's co-authors include Gary E. Gallick, Justin M. Summy, Serk In Park, Lee M. Ellis, Ami N. Shah, Jing Zhang, Charles A. Staley, T. Christopher Windham, Donald P. Lesslie and Corazon D. Bucana and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Nila U. Parikh

39 papers receiving 2.4k citations

Peers

Nila U. Parikh

ONCOL

PRM

PFM

Justin M. Summy United States

Randall Schreck United States

Jane Kendrew United Kingdom

William M. Merritt United States

Marina Holgado-Madruga United States

Andreas Gschwind Germany

Qunsheng Ji China

Keith Orford United States

T. Annie T. Fong United States

Jalila Adnane United States

Justin M. Summy United States

Nila U. Parikh

1.5k ×1.0

1.3k ×1.0

ONCOL

417 ×0.8

315 ×1.0

PRM

191 ×0.7

PFM

Citations per year, relative to Nila U. Parikh Nila U. Parikh (= 1×) peers Justin M. Summy

Countries citing papers authored by Nila U. Parikh

Since Specialization

Citations

This map shows the geographic impact of Nila U. Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nila U. Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nila U. Parikh more than expected).

Fields of papers citing papers by Nila U. Parikh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nila U. Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nila U. Parikh. The network helps show where Nila U. Parikh may publish in the future.

Co-authorship network of co-authors of Nila U. Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Nila U. Parikh. A scholar is included among the top collaborators of Nila U. Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nila U. Parikh. Nila U. Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parseghian, Christine M., Nila U. Parikh, Ji Yuan Wu, et al.. (2017). Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 23(15). 4146–4154. 47 indexed citations

Varkaris, Andreas, Paul G. Corn, Nila U. Parikh, et al.. (2015). Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer. Clinical Cancer Research. 22(1). 107–121. 37 indexed citations

Lee, Yu-Chen, Song-Chang Lin, Guoyu Yu, et al.. (2015). Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Research. 75(22). 4949–4959. 36 indexed citations

Reddy, Sangeetha M., Scott Kopetz, Jeffrey S. Morris, et al.. (2015). Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer. Investigational New Drugs. 33(4). 977–984. 33 indexed citations

Kopetz, Scott, Van K. Morris, Nila U. Parikh, et al.. (2014). Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer. BMC Cancer. 14(1). 660–660. 15 indexed citations

Bartley, Angela N., Nila U. Parikh, Chiu‐Hsieh Hsu, et al.. (2013). Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal Neoplasia. Cancer Prevention Research. 6(11). 1162–1170. 10 indexed citations

Sen, Banibrata, Babita Saigal, Nila U. Parikh, Gary E. Gallick, & Faye M. Johnson. (2009). Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase–STAT3 Binding. Cancer Research. 69(5). 1958–1965. 100 indexed citations

Kopetz, Scott, Donald P. Lesslie, Serk In Park, et al.. (2009). Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress. Cancer Research. 69(9). 3842–3849. 127 indexed citations

Araujo, John C., Ann T. Poblenz, Nila U. Parikh, et al.. (2009). Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation. Cancer Biology & Therapy. 8(22). 2153–2159. 36 indexed citations

10.

Parikh, Nila U., et al.. (2007). Inhibition of colon tumor metastasis in orthotopic nude mouse models with the dual-selective Src/Abl kinase inhibitor, AZD0530. Molecular Cancer Therapeutics. 6. 1 indexed citations

11.

Shah, Ami N., Justin M. Summy, Jing Zhang, et al.. (2007). Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells. Annals of Surgical Oncology. 14(12). 3629–3637. 367 indexed citations

12.

Lesslie, Donald P., Nila U. Parikh, Ami N. Shah, et al.. (2006). Combined activity of dasatinib (BMS-354825) and oxaliplatin in an orthotopic model of metastatic colorectal carcinoma. Cancer Research. 66. 1114–1114. 4 indexed citations

13.

Landen, Charles N., Chunhua Lu, Liz Y. Han, et al.. (2006). Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer. JNCI Journal of the National Cancer Institute. 98(21). 1558–1570. 99 indexed citations

14.

Lesslie, Donald P., Justin M. Summy, Nila U. Parikh, et al.. (2006). Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. British Journal of Cancer. 94(11). 1710–1717. 101 indexed citations

15.

Cabıoğlu, Neslihan, Justin M. Summy, Claudia P. Miller, et al.. (2005). CXCL-12/Stromal Cell–Derived Factor-1α Transactivates HER2-neu in Breast Cancer Cells by a Novel Pathway Involving Src Kinase Activation. Cancer Research. 65(15). 6493–6497. 129 indexed citations

16.

Bauer, Todd W., Fan Fan, Wenbiao Liu, et al.. (2005). Insulinlike Growth Factor-I???Mediated Migration and Invasion of Human Colon Carcinoma Cells Requires Activation of c-Met and Urokinase Plasminogen Activator Receptor. Annals of Surgery. 241(5). 748–758. 54 indexed citations

17.

Wiener, Jon R., T. Christopher Windham, Verónica Estrella, et al.. (2002). Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers. Gynecologic Oncology. 88(1). 73–79. 144 indexed citations

18.

Windham, T. Christopher, Nila U. Parikh, Doris R. Siwak, et al.. (2002). Src activation regulates anoikis in human colon tumor cell lines. Oncogene. 21(51). 7797–7807. 173 indexed citations

19.

Marchetti, Dario, Nila U. Parikh, Marius Sudol, & Gary E. Gallick. (1998). Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells. Oncogene. 16(25). 3253–3260. 40 indexed citations

20.

Ellis, Lee M., Charles A. Staley, Wenbiao Liu, et al.. (1998). Down-regulation of Vascular Endothelial Growth Factor in a Human Colon Carcinoma Cell Line Transfected with an Antisense Expression Vector Specific for c-src. Journal of Biological Chemistry. 273(2). 1052–1057. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact